|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.85 CAD | -0.03% |
|
-0.41% | +10.76% |
| 12-01 | KDA Group Rolls Out Medherize Platform to Pharmacies | MT |
| 11-26 | Metro Inc.'s Equity Buyback announced on November 20, 2024, has expired. | CI |
| Capitalization | 21.47B 15.49B 13.31B 12.47B 11.63B 1,394B 23.36B 146B 56.33B 658B 58.13B 56.89B 2,407B | P/E ratio 2025 |
19.9x | P/E ratio 2026 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise value | 24.96B 18.01B 15.48B 14.5B 13.51B 1,620B 27.15B 170B 65.48B 765B 67.58B 66.14B 2,798B | EV / Sales 2025 |
0.91x | EV / Sales 2026 * | 1.1x |
| Free-Float |
99.47% | Yield 2025 * |
1.47% | Yield 2026 * | 1.62% |
Last Transcript: Metro Inc.
| 1 day | -0.03% | ||
| 1 week | -0.41% | ||
| Current month | -0.41% | ||
| 1 month | +5.30% | ||
| 3 months | +2.61% | ||
| 6 months | -4.62% | ||
| Current year | +10.76% |
| 1 week | 97.9 | 101.3 | |
| 1 month | 94.03 | 101.3 | |
| Current year | 87.76 | 109.2 | |
| 1 year | 87.76 | 109.2 | |
| 3 years | 65.42 | 109.2 | |
| 5 years | 52.63 | 109.2 | |
| 10 years | 37.75 | 109.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric la Flèche
CEO | Chief Executive Officer | 62 | 2008-03-31 |
Marc Giroux
COO | Chief Operating Officer | - | - |
Frédéric Legault
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Eric la Flèche
BRD | Director/Board Member | 62 | 2008-03-31 |
Maryse Bertrand
BRD | Director/Board Member | 65 | 2015-02-10 |
Stephanie Coyles
BRD | Director/Board Member | 57 | 2015-02-10 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.03% | -0.41% | +7.14% | +28.77% | 15.49B | ||
| +0.24% | +4.16% | +20.28% | +130.39% | 917B | ||
| 0.00% | +0.27% | +29.72% | +105.44% | 52.91B | ||
| -3.83% | -10.80% | +105.77% | +171.62% | 44.9B | ||
| -0.68% | -6.79% | +5.88% | +35.36% | 40.26B | ||
| +0.22% | +0.60% | +23.47% | +97.82% | 38.63B | ||
| +0.92% | -1.80% | +7.72% | +23.60% | 36.3B | ||
| -0.46% | -4.07% | -9.45% | -13.24% | 35B | ||
| -0.42% | -0.40% | +22.14% | +67.95% | 26.29B | ||
| -0.07% | +0.17% | -1.84% | -15.53% | 23.79B | ||
| Average | -0.41% | -1.91% | +21.08% | +63.22% | 123.1B | |
| Weighted average by Cap. | +0.03% | +2.34% | +21.67% | +114.02% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 22.01B 15.87B 13.65B 12.78B 11.91B 1,429B 23.94B 150B 57.73B 675B 59.58B 58.31B 2,467B | 22.69B 16.37B 14.07B 13.18B 12.29B 1,473B 24.68B 154B 59.53B 696B 61.44B 60.13B 2,544B |
| Net income | 990M 714M 614M 575M 536M 64.27B 1.08B 6.73B 2.6B 30.35B 2.68B 2.62B 111B | 1.06B 765M 657M 616M 574M 68.81B 1.15B 7.2B 2.78B 32.5B 2.87B 2.81B 119B |
| Net Debt | 3.49B 2.52B 2.16B 2.03B 1.89B 226B 3.79B 23.7B 9.15B 107B 9.44B 9.24B 391B | 3.56B 2.57B 2.21B 2.07B 1.93B 231B 3.88B 24.21B 9.35B 109B 9.65B 9.44B 399B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 99.85 $ | -0.03% | 269,184 |
| 25-12-04 | 99.88 $ | +1.51% | 487,655 |
| 25-12-03 | 98.39 $ | -1.32% | 418,249 |
| 25-12-02 | 99.71 $ | -1.09% | 366,920 |
| 25-12-01 | 100.81 $ | +0.55% | 469,672 |
Delayed Quote Toronto S.E., December 05, 2025 at 04:19 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRU Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















